Review article · 2021 · Open access

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Charlotte Elisabeth Teunissen, Inge M.W. Verberk, Elisabeth H Thijssen, Lisa Vermunt, Oskar Hansson, Henrik Zetterberg, Wiesje M. van der Flier, Michelle M Mielke, Marta del Campo

The Lancet Neurology, 21(1), 66–77 · Published 24 November 2021 · DOI 10.1016/s1474-4422(21)00361-6

Open PDFView at the publisherCite this paper

In brief

“Blood-based biomarkers for Alzheimer's disease: towards clinical implementation” is a 2021 review article by Charlotte Elisabeth Teunissen and 8 co-authors, published in The Lancet Neurology. OpenAlex counts 1,193 citations as of 19 November 2026, which puts it in the top 1% of works published in 2021 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Amsterdam UMC (VU Amsterdam) - Institutional Repository.

Citations
1,193
Most cited in
2026 (331)
Field-weighted impact
21.45
References
118
Authors
9

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Teunissen, C. E., Verberk, I. M., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2021). Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet Neurology, 21(1), 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6

MLA 9

Teunissen, Charlotte Elisabeth, et al. “Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.” The Lancet Neurology, vol. 21, no. 1, 2021, pp. 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6.

Chicago

Teunissen, Charlotte Elisabeth, Inge M.W. Verberk, Elisabeth H Thijssen, Lisa Vermunt, Oskar Hansson, Henrik Zetterberg, Wiesje M. van der Flier, Michelle M Mielke, and Marta del Campo. 2021. “Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.” The Lancet Neurology 21 (1): 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6.

Harvard

Teunissen, C. E. et al. (2021) ‘Blood-based biomarkers for Alzheimer's disease: towards clinical implementation’, The Lancet Neurology, 21(1), pp. 66–77. doi:10.1016/s1474-4422(21)00361-6.

IEEE

C. E. Teunissen et al., “Blood-based biomarkers for Alzheimer's disease: towards clinical implementation,” The Lancet Neurology, vol. 21, no. 1, pp. 66–77, 2021, doi: 10.1016/s1474-4422(21)00361-6.

BibTeX

@article{teunissen2021blood,
  title     = {{Blood-based biomarkers for Alzheimer's disease: towards clinical implementation}},
  author    = {Teunissen, Charlotte Elisabeth and Verberk, Inge M.W. and Thijssen, Elisabeth H and Vermunt, Lisa and Hansson, Oskar and Zetterberg, Henrik and van der Flier, Wiesje M. and Mielke, Michelle M and del Campo, Marta},
  journal   = {The Lancet Neurology},
  year      = {2021},
  volume    = {21},
  number    = {1},
  pages     = {66--77},
  doi       = {10.1016/s1474-4422(21)00361-6},
  url       = {https://doi.org/10.1016/s1474-4422(21)00361-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
2022116116
2023236236
2024273273
2025235235
2026331331

Its field-weighted citation impact is 21.45: it has been cited 21.45 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • Alzheimer's disease
  • blood-based biomarkers
  • amyloid
  • phosphorylated tau
  • neurofilament light chain
  • glial fibrillary acidic protein
  • cerebrospinal fluid biomarkers
  • amyloid PET

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Teunissen, C. E., Verberk, I. M., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2021). Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet Neurology, 21(1), 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6

How many times has this paper been cited?

1,193 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Amsterdam UMC (VU Amsterdam) - Institutional Repository: sign in and open the PDF from this page.

Who wrote this paper?

Charlotte Elisabeth Teunissen, Inge M.W. Verberk, Elisabeth H Thijssen, Lisa Vermunt, Oskar Hansson, Henrik Zetterberg, Wiesje M. van der Flier, Michelle M Mielke, Marta del Campo.

What is the DOI of this paper?

10.1016/s1474-4422(21)00361-6, permanently at https://doi.org/10.1016/s1474-4422(21)00361-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.